Immunocore and Medison Pharma collaborate to market Tebentafusp in Canada

- Advertisement -

Ontario, Canada (CU)_ Immunocore, which is a late-stage biotechnology firm creating a unique class of bispecific T cell receptor (TCR) bispecific immunotherapies for the treatment of a variety of diseases, including…

Hot this week

Canadians opting for travel alternatives amid tensions in Cuba, Mexico

Many Canadians are opting for alternative March ‘26 vacation...

UK’s Starmer defends actions over Iran

Starmer defends his decision, citing law and national interest....

From Campus Crisis to Reinvention? Why AI and Declining Enrolment Are Forcing US Universities to Change

Declining enrolment, university funding cuts, advancing AI, and evolving...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories